923274-69-5

Basic information

• Product Name: 4-Isopropylthiazole-2-carboxylic acid (6-carbamoyl-3-methoxy-2-methyl-phenyl)-amide
• Synonyms: 4-Isopropylthiazole-2-carboxylic acid (6-carbamoyl-3-methoxy-2-methyl-phenyl)-amide
• CAS NO: 923274-69-5
• Molecular Weight: 333.411
• Mol File: 923274-69-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-Isopropylthiazole-2-carboxylic acid (6-carbamoyl-3-methoxy-2-methyl-phenyl)-amide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Isopropylthiazole-2-carboxylic acid (6-carbamoyl-3-methoxy-2-methyl-phenyl)-amide(923274-69-5)
• EPA Substance Registry System: 4-Isopropylthiazole-2-carboxylic acid (6-carbamoyl-3-methoxy-2-methyl-phenyl)-amide(923274-69-5)

Safety Data

• Hazardous Substances Data: 923274-69-5(Hazardous Substances Data)

Upstream product

• 300831-06-5 4-isopropylthiazole-2-carboxylic acid 
• 922520-33-0 2-amino-4-methoxy-3-methyl benzamide 
• 923274-68-4 2-amino-4-methoxy-3-methylbenzonitrile 
• 72817-94-8 4-amino-5-cyano-2-hydroxy-3-methylbenzoic acid 
• 72817-85-7 4-Amino-5-cyan-3-methyl-salicylsaeure-ethylester 
• 102569-26-6 2-amino-4-hydroxy-3-methylbenzonitrile 
• 19967-55-6 1-bromo-3-methyl-2-butanone 
• 156589-82-1 4-(1-methylethyl)thiazole-2-carboxylic acid ethyl ester 

Relevant articles and documents

Macrocylic Inhibitors of Hepatitis C Virus

Compounds of the formula I: and N-oxides, salts, and stereoisomers thereof wherein A is OR1, NHS(═O)pR2; wherein; R1 is hydrogen, C1-C6alkyl, C0-C3alkylenecarbocyclyl, C0-C3alkylene-heterocyclyl;R2 is C1-C6alkyl, C0-C3alkylenecarbocyclyl, C0-C3alkyleneheterocyclyl;p is independently 1 or 2;n is 3, 4, 5 or 6; — denotes an optional double bond;L is N or CRz; Rz is H or forms a double bond with the asterisked carbon;Rq is H or when L is CRz, Rq can also be C1-C6alkyl;Rr is quinazolinyl, optionally substituted with one two or three substituents each independently selected from C1-C6 alkyl, C1-C6alkoxy, hydroxyl, halo, haloC1-C6alkyl, amino, mono- or dialkylamino, mono- or dialkylaminocarbonyl, C1-C6alkyl-carbonylamino, C0-C3alkylenecarbocyclyl and C0-C3 alkyleneheterocyclyl;R5 is hydrogen, C1-C6alkyl, C1-C6alkoxyC1-C6alkyl or C3-C7cycloalkyl;R6 is hydrogen, C1-C6alkyl, C1-C6alkoxy, C0-C3alkylenecarbocyclyl, C0-C3alkylene-heterocyclyl, hydroxy, bromo, chloro or fluoro have utility in the treatment or prophylaxis of flaviviral infections such as HCV